A Study of Treatment Patterns and Annualized Relapse Rate in Multiple Sclerosis Patients Who Escalate Versus Continue Disease-Modifying Therapies Following Relapse
Clinical trial NCT07743281 · COMPLETED
Trial details
- NCT number
- NCT07743281
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2025-03-10
- Primary completion
- 2025-07-30
- Enrollment
- 753
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.